DE69734392D1 - Impfstoff gegen tumore der b-lymphozyten - Google Patents

Impfstoff gegen tumore der b-lymphozyten

Info

Publication number
DE69734392D1
DE69734392D1 DE69734392T DE69734392T DE69734392D1 DE 69734392 D1 DE69734392 D1 DE 69734392D1 DE 69734392 T DE69734392 T DE 69734392T DE 69734392 T DE69734392 T DE 69734392T DE 69734392 D1 DE69734392 D1 DE 69734392D1
Authority
DE
Germany
Prior art keywords
lymphocytes
against tumors
vaccinate against
cytokine
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69734392T
Other languages
English (en)
Other versions
DE69734392T2 (de
Inventor
C Popescu
Larry Kwak
C Ochoa
Larry Boni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomira USA Inc
Original Assignee
Biomira USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira USA Inc filed Critical Biomira USA Inc
Publication of DE69734392D1 publication Critical patent/DE69734392D1/de
Application granted granted Critical
Publication of DE69734392T2 publication Critical patent/DE69734392T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69734392T 1996-02-16 1997-02-13 Impfstoff gegen tumore der b-lymphozyten Expired - Fee Related DE69734392T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1178396P 1996-02-16 1996-02-16
US11783P 1996-02-16
PCT/US1997/002351 WO1997029769A1 (en) 1996-02-16 1997-02-13 Vaccine for b-cell malignancies

Publications (2)

Publication Number Publication Date
DE69734392D1 true DE69734392D1 (de) 2006-03-02
DE69734392T2 DE69734392T2 (de) 2006-07-13

Family

ID=21751949

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69734392T Expired - Fee Related DE69734392T2 (de) 1996-02-16 1997-02-13 Impfstoff gegen tumore der b-lymphozyten

Country Status (8)

Country Link
US (2) US6312718B1 (de)
EP (1) EP0918539B1 (de)
JP (1) JP3948751B2 (de)
AT (1) ATE306937T1 (de)
AU (1) AU2273497A (de)
CA (1) CA2246708C (de)
DE (1) DE69734392T2 (de)
WO (1) WO1997029769A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190388B (de) * 1997-10-01 2003-07-26 Biomira Usa Inc
EP1523977A1 (de) * 1997-10-01 2005-04-20 Biomira Usa Inc. Biologisch aktive Verbindungen enthaltende multilamellare Koaleszenzvesikel (MLCV)
US6207170B1 (en) 1998-01-16 2001-03-27 Biomira U.S.A., Inc. Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
CA2318556A1 (en) * 1998-01-16 1999-07-22 Biomira, Inc. Lipomatrix preparation
DE19954843C2 (de) * 1999-11-09 2003-11-20 Novosom Ag Verfahren zur Verkapselung von Proteinen oder Peptiden in Liposomen, mit dem Verfahren hergestellte Liposomen und deren Verwendung
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
US20030012782A1 (en) * 2000-08-11 2003-01-16 Gold Daniel P. Method and composition for altering a T cell mediated pathology
JP2005525992A (ja) * 2001-06-25 2005-09-02 イサム・リサーチ・デベロツプメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシテイ・オブ・エルサレム 生物学的物質を充填した小胞の調製法およびそれらの様々な使用
FR2934498B1 (fr) * 2008-08-01 2014-08-15 Commissariat Energie Atomique Utilisation d'une forme soluble d'hla-g dans le traitement des proliferations anormales des lymphocytes b.
US8647627B2 (en) * 2011-01-13 2014-02-11 Oncbiomune, L.L.C. Composition for a cancer vaccine
US9725768B2 (en) 2012-08-31 2017-08-08 Biovest International, Inc. Methods for producing high-fidelity autologous idiotype vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036945A (en) 1976-05-03 1977-07-19 The Massachusetts General Hospital Composition and method for determining the size and location of myocardial infarcts
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
DE68927679T2 (de) * 1988-10-27 1997-06-26 Univ Minnesota Immunhilfsmittel aus Liposome enthaltend Lymphokin IL -2
WO1994008601A1 (en) * 1992-10-14 1994-04-28 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of b cell lymphoma tumor resistance using idiotype/cytokine conjugates
US5861158A (en) * 1993-11-17 1999-01-19 The United States Of America As Represented By The Deptartment Of Health And Human Services Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor

Also Published As

Publication number Publication date
EP0918539B1 (de) 2005-10-19
CA2246708C (en) 2005-06-14
US20030021838A1 (en) 2003-01-30
JP3948751B2 (ja) 2007-07-25
EP0918539A1 (de) 1999-06-02
CA2246708A1 (en) 1997-08-21
US6312718B1 (en) 2001-11-06
WO1997029769A1 (en) 1997-08-21
EP0918539A4 (de) 2001-04-11
ATE306937T1 (de) 2005-11-15
AU2273497A (en) 1997-09-02
JP2000507214A (ja) 2000-06-13
DE69734392T2 (de) 2006-07-13

Similar Documents

Publication Publication Date Title
ITMI913513A0 (it) Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
DE69734392D1 (de) Impfstoff gegen tumore der b-lymphozyten
ATE422352T1 (de) Liposomaler grippeimpfstoff und verfahren
IT8822145A0 (it) Vaccini contenenti antigeni tumorali e coadiuvanti e relativo procedimento di preparazione
IL125608A0 (en) Tumor associated antigen peptides and use of same as anti-tumor vaccines
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
NO944475D0 (no) Kombinerte vaksiner omfattende Hepatit B overflateantigen og andre antigener
ATE298580T1 (de) Eigenschaften von poly(amidoamine) dendrimeren als adjuvantien
AR027680A1 (es) Vacuna contra la salmonella materiales y metodos
ATE261314T1 (de) P53 impfstoff
IT238082Y1 (it) Gruppo motore doppio per la movimentazione di schienale e poggiapiediin poltrone e simili
IS6156A (is) Samsettar ónæmisglæðablöndur
NZ511445A (en) Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
IT1217803B (it) Copoliestrere termotropico e procedimento per la sua preparazione e suo uso
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
IT1217177B (it) Palmitoil-fruttosio-1,6-difosfato,suo uso terapeutico e relativi metodi di preparazione
ITUD930070A0 (it) Mobile per sedersi idoneo ad essere trasformato in mobile per sdraiarsi
IT221066Z2 (it) Supporto adattabile per colture in vaso e simili
IT221102Z2 (it) Dispositivo per colture in vaso e simili
BR1100913A (pt) Vacinas combinadas compreendendo o antìgeno superficial da hepatite b e outros antìgenos
IT8536297V0 (it) Dispositivo di supporto per bruciare zollette,in particolare per la preparazione di aperitivi e simili
DE216901T1 (de) Immunogenes antigen-traeger-proteinkonjugat zur verwendung in impfstoffen gegen malaria.
IL141093A0 (en) Tumor associated antigen peptides and use of same as anti-tumor vaccines
IT1191390B (it) Dispositivo di supporto ad altezza regolabile particolarmente per sedie,poltrone,sgabelli e simili

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee